FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: an Austrian observational Tri-Center comparative effectiveness analysis [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:J. Riedl, F. Posch, L. Horvath, A. Gantschnigg, F. Renneberg, E. Schwarzenbacher, F. Moik, D. Barth, R. Schaberl-Moser, M. Stotz, Martin PichlerGND, H. Stöger, R. Greil, A. Djanani, K. Schlick, A. Gerger
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/101731
ISSN:2296-5262OPAC
Parent Title (English):Oncology Research and Treatment
Publisher:Karger
Place of publication:Basel
Type:Article
Language:English
Year of first Publication:2020
Release Date:2023/02/06
Volume:43
Issue:Suppl. 4
First Page:215
DOI:https://doi.org/10.1159/000510995
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für Translationale Krebsforschung